Comparison of KRAS/BRAF mutations between primary tumors and serum in colorectal cancer: Biological and clinical implications

By                    

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 249-254

Spandidos Publications

Access to resources Recommend Favorite

KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma

By          

Oncology Letters, Vol. 8, Iss. 4, 2014-01 ,pp. : 1422-1426

Spandidos Publications

Access to resources Recommend Favorite

KRAS mutational status analysis of peripheral blood isolated circulating tumor cells in metastatic colorectal patients

By          

Oncology Letters, Vol. 6, Iss. 5, 2013-01 ,pp. : 1343-1345

Spandidos Publications

Access to resources Recommend Favorite

EGFR Mutations, Gene Amplification, and Protein Expression and KRAS Mutations in Primary and Metastatic Tumors of Nonsmall Cell Lung Cancers and Their Clinical Implications: A Meta-Analysis

By Han Chengbo   Ma Jietao   Zhao Jianzhu   Zhou Yang   Jing Wei   Zou Huawei  

Cancer Investigation, Vol. 29, Iss. 9, 2011-10 ,pp. : 626-634

Informa Healthcare

Access to resources Recommend Favorite

Analysis of PTEN, BRAF and PI3K status for determination of benefit from cetuximab therapy in metastatic colorectal cancer patients refractory to chemotherapy with wild-type KRAS

By Tural Deniz   Batur Sebnem   Erdamar Sibel   Akar Emre   Kepil Nuray   Mandel Nil   Serdengeçti Süheyla  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1041-1049

Springer Publishing Company

Access to resources Recommend Favorite